ESG

A new AI-powered venture is giving abandoned gene therapies a second chance, challenging traditional pharma models to bring hope to rare disease patients.

Heybike storms CES with seven new e-bikes and a dirt bike, betting on advanced tech and a lifestyle philosophy to conquer diverse new markets.

A unique Boulder project tackles the housing crisis with modular homes, student builders, and a vision for a sustainable, replicable community model.

ALSAC appoints a powerhouse duo, blending deep donor expertise with AI-driven strategy to fuel St. Jude's ambitious $12.9 billion global expansion.

A new smart light switch unveiled at CES 2026 needs no batteries or wires, merging luxury design with revolutionary energy-harvesting technology.

A new partnership will turn 50+ former landfills into solar farms, promising clean energy, local jobs, and a solution to America's land-use puzzle.

Acertis Pharmaceuticals secures rights to Licart, a unique once-daily NSAID patch, aiming to disrupt the competitive U.S. topical pain relief market.

Employer health plans are using 'alternative funding' to cut costs, but critics warn these schemes force patients to use risky, non-FDA approved drugs.

BizClik’s Net Zero Summit will feature an SGS workshop to help leaders turn complex ESG regulations into a strategic advantage amid global compliance shifts.

From AI-powered diagnostics to non-hallucinogenic psychedelics, 2025's discoveries are redefining mental healthcare and offering new hope.

A new multi-year deal for advanced battery materials highlights Volkswagen's push for supply chain control and Cabot's strategic green energy pivot.

Atmus Filtration Technologies acquires Koch Filter for $450M in a major market expansion, while ADTi names a new CEO to lead a sharpened strategic focus.

Employee-owned SSC CPAs + Advisors merges with Oklahoma's Harrison Henderson, expanding its footprint and bringing its unique ownership model to new markets.

Lifepoint Health partners with iScribeHealth, deploying ambient AI scribes across its network to reduce documentation and improve patient care.

Unveiled in historic Cherry Brook, NS, the new theme celebrates three decades of Black brilliance and charts a course for future generations.

Teal Health's FDA-authorized Teal Wand is now available in all 50 states, aiming to revolutionize preventive care for millions of overdue women.

A Boston biotech, armed with $62M and a new name, unveils a plan to build a universal model of the cell, aiming to predict and control its behavior.

The digital-native waterproof shoe brand Vessi opens its first U.S. store, blending online savvy with a physical footprint and community support.

Palisade Bio's PALI-2108, a drug targeting IBD at its source, secures a key investment, offering hope for a new era of treatment with fewer side effects.

Navan CEO Ariel Cohen will pitch his growth strategy at the Needham conference, a key test for the travel tech firm amid stock declines and high hopes.